| Record Information |
| Version |
3.5 |
| Creation Date |
2006-08-13 09:00:41 -0600 |
| Update Date |
2013-02-08 17:13:07 -0700 |
| HMDB ID |
HMDB04239 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
13,14-Dihydro PGF2a |
| Description |
13,14-dihydro PGF2a is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207 )Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (5Z,9-alpha,11-alpha,15S)-9,11,15-trihydroxy-Prost-5-en-1-oate
- (5Z,9-alpha,11-alpha,15S)-9,11,15-trihydroxy-Prost-5-en-1-oic acid
- 13,14-Dihydro-pgf2-alpha
- 13,14-Dihydrodinoprost
- 13,14-Dihydroprostaglandin F2-alpha
- 13,14-Dihydroprostaglandin F2alpha
- 7-(3,5-Dihydroxy-2-(3-hydroxyoctyl)cyclopentyl)-5-Heptenoate
- 7-(3,5-Dihydroxy-2-(3-hydroxyoctyl)cyclopentyl)-5-Heptenoic acid
|
| Chemical Formula |
C20H36O5 |
| Average Molecular Weight |
356.4968 |
| Monoisotopic Molecular Weight |
356.256274262 |
| IUPAC Name |
(5E)-7-[3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl]hept-5-enoic acid |
| Traditional IUPAC Name |
(5E)-7-[3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl]hept-5-enoic acid |
| CAS Registry Number |
27376-74-5 |
| SMILES |
CCCCCC(O)CCC1C(O)CC(O)C1C\C=C\CCCC(O)=O |
| InChI Identifier |
InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,15-19,21-23H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4+ |
| InChI Key |
LLQBSJQTCKVWTD-QPJJXVBHSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Eicosanoids |
| Sub Class |
Prostaglandins and related compounds |
| Other Descriptors |
- Aliphatic Homomonocyclic Compounds
- Carbocyclic Fatty Acids
- Organic Compounds
- Unsaturated Fatty Acids
|
| Substituents |
- Carboxylic Acid
- Cyclic Alcohol
- Secondary Alcohol
|
| Direct Parent |
Prostaglandins and related compounds |
| Ontology |
| Status |
Expected and Not Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Fuel and energy storage
- Fuel or energy source
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
2.183 |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
Not Available
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
Not Available |
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB023344 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
4938997  |
| KEGG Compound ID |
Not Available |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB04239  |
| Metagene Link |
HMDB04239  |
| METLIN ID |
Not Available |
| PubChem Compound |
6434009  |
| PDB ID |
Not Available |
| ChEBI ID |
Not Available |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
Not Available
|